France Expands Reimbursed Compassionate Access for Botensilimab/Balstilimab to Ovarian Cancer and Soft-Tissue Sarcomas

Botensilimab/Balstilimab

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

Syria And Hematogenix Sign Agreement To Establish Advanced Cancer Center In Damascus

Syria And Hematogenix Sign Agreement - OncoDaily

The Onco-Bronchology International Conference (Onco-Broncho 2026)

Onco-Bronchology

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

Merck Could Strike 30 Billion Deal for Revolution Medicines

merck

Jeffrey Bluestone: Kick-Ass Science, Collaborate Like Hell, Make a Difference

Jeffrey Bluestone

Take home messages